Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and ...

Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated ...

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that a ...

Seven London Muslim centres have been defaced with racist graffiti in two weeks. The mosques, community centres, and primary ...

Veralto (NYSE: VLTO) (the "Company"), a global leader in essential water and product quality solutions dedicated to ...

The Parade will conclude at the Waltham Common, where the City’s Annual Holiday Lighting festivities will will begin around 4:30 p.m. Santa is also holding court at the nearby Natick Mall ...

WALTHAM, Mass., January 23, 2025--(BUSINESS WIRE)--The Board of Directors of Revvity (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is ...

Harp & Harp has won planning consent for ‘Sunnyside’, a contemporary housing development in east London The project will see ...

PEMGARDA™ (pemivibart) net product revenue of $13.8 million, 48% growth over Q3 2024 net product revenue of $9.3 ...

Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a growing $22.8 billion therapeutics market. Read the IPO report here ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...